Biju Chorinchath

Biju Chorinchath currently serves as Vice President of Healthcare Systems, Access, Patient Services, and Head of the Biomaterials Business Unit at Octapharma, having joined the company in May 2025. Biju is a member of the Octapharma-US Executive leadership team and oversees the adoption of Octapharma brands across various strategic accounts. Prior to this role, Biju held the position of Head of US Marketing, Business Development, Market Access, and Channel Operations at Almirall from November 2019 to May 2025, managing P&L responsibilities as a member of the US Executive Management Team. Biju's earlier experience includes positions at CSL Behring as Franchise Head for Immunology and Neurology, Sobi as VP and Head of Business Development, Marketing, and Commercial Operations in North America, and Wyeth Pharmaceuticals as Director of Marketing, where Biju contributed to the success of several iconic brands. Biju holds a Master's degree in Health Policy and Management from Harvard University and a Master's degree in Immunology from Texas A&M University.